Our HTA Solutions
Effective diffusion of health technology into any healthcare system depends on the robustness of its multidisciplinary policy analysis aka Health Technology Assessment (HTA). Our HTA team of experts offers niche expertise to fulfill your HTA goals.
Clinical Research and Development (R&D)
Know how our early HTA insights help pharmaceutical companies with focused R&D activities and accurate portfolio-planning
Expedite your regulatory submissions with HTA evidence supplements based on our guidance on a new or existing health technology.
Pricing and Reimbursement
Realize your product’s clinical, economic, and humanistic values through HTA performed by us to devise effective pricing and reimbursement strategies.
Leverage our value-communication expertise to ensure smooth market access with no regulatory hurdles for your product. Our cutting-edge platform, MaiA, is intended to simplify the whole clinical reporting procedure including DSUR Automation. Our solution merges regulatory information, the corporate product portfolio, and internal procedures to produce a single system, from scheduling through distribution and tracking of compliance KPIs. Our automated, adaptable, and proactive systems assist firms in reducing their report output and effectively and economically complying with regulatory obligations.
The success of healthcare decision making lies in the science behind the HTA. With an intensive approach, we ensure neutral evidence generation and thereby maximize product value for your drug or medical device.
- HTA Topic Selection
- HTA for Drugs
- HTA for Medical Devices
- Equity Assessment in HTA
- Health Economic Evaluation
- Economic Evidence Synthesis
- Healthcare Decision Analytic Models
There is only one connecting dot between compelling HTA recommendations and informed decision making – HTA value story. And who else can be the single stop solution than our experienced team of health research and advocacy storytellers to make this a reality for you!
Our authoring solutions offerings include:
- HTA Submissions
- HTA Protocol for Innovative Technology
- HTA report based on findings from clinical and cost-effectiveness
- Ethical and/or Equity Aspects in HTA report
- HTA conference abstracts/posters
- Stakeholder Consultation Minutes/Deliberation document
- Evidence-based policy briefs
HTA Capacity Building
Keeping pace with the rapidly evolving pharma industry and global interest in universal health coverage, it is the right time to invest in skill development. Our astute trainers understand HTA training needs for your organization and offer you curtailed training materials specific to your business.
Our broad training areas are:
- HTA overview
- HTA for Pharma
- HTA for MedTech
- HTA in Public Health
- Hospital-based HTA
- Economic Evaluation in HTA
- Bioethics in HTA